AHA 2013:EDTA螯合剂或降伴糖尿病心梗患者的心血管事件

2013-11-27 高晓方 译 医学论坛网

于AHA 2013科学年会公布的美国一项研究表明,在年龄大于50岁且伴有糖尿病的心肌梗死后患者中,EDTA螯合剂治疗可显著减少心血管事件。但该研究并未充分证明对所有的伴糖尿病心梗后患者常规用螯合疗法。论文11月19日在线发表于《循环》(Circulation)。 【原文下载】 此项TACT研究以年龄≥50岁且既往伴有心肌梗死的患者为受试者,共633例糖尿病患者,被随机分为

于AHA 2013科学年会公布的美国一项研究表明,在年龄大于50岁且伴有糖尿病的心肌梗死后患者中,EDTA螯合剂治疗可显著减少心血管事件。但该研究并未充分证明对所有的伴糖尿病心梗后患者常规用螯合疗法。论文11月19日在线发表于《循环》(Circulation)。 【原文下载】

此项TACT研究以年龄≥50岁且既往伴有心肌梗死的患者为受试者,共633例糖尿病患者,被随机分为EDTA螯合剂组(322例)或安慰剂组(311例)。主要终点为死亡、心梗再发、卒中、冠脉血运重建或心绞痛住院;次要终点为心血管死亡、心梗再发或卒中。

结果显示,在633例(37%)糖尿病患者中,EDTA组的5年主要终点发生率显著降低(25%对38%;危险比[HR] 0.59)。对多亚组实施Bonferroni校正之后上述结果依然具有显著性(校正P=0.002)。EDTA组的全因死昂率和次要终点发生率均显著降低,但对多亚组进行校正之后显著性消失。减少1项主要终点的需治疗数为6.5。在1075例非糖尿病患者中相关事件则无减少。

原文出处:

Escolar E, Lamas GA, Mark DB, Boineau R, Goertz C, Rosenberg Y, Nahin RL, Ouyang P, Rozema T, Magaziner A, Nahas R, Lewis EF, Lindblad L, Lee KL.The Effect of an EDTA-based Chelation Regimen on Patients With Diabetes Mellitus and Prior Myocardial Infarction in the Trial to Assess Chelation Therapy (TACT).Circ Cardiovasc Qual Outcomes. 2013 Nov 19. 【原文下载】

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2049442, encodeId=3ffe204944283, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sat May 03 13:29:00 CST 2014, time=2014-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643328, encodeId=9d2116433289b, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Jun 16 03:29:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267196, encodeId=fc1c126e19600, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537050, encodeId=bedc153e0502e, content=<a href='/topic/show?id=aaaf653e44' target=_blank style='color:#2F92EE;'>#EDTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6537, encryptionId=aaaf653e44, topicName=EDTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=328c12785299, createdName=ycmayy, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2049442, encodeId=3ffe204944283, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sat May 03 13:29:00 CST 2014, time=2014-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643328, encodeId=9d2116433289b, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Jun 16 03:29:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267196, encodeId=fc1c126e19600, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537050, encodeId=bedc153e0502e, content=<a href='/topic/show?id=aaaf653e44' target=_blank style='color:#2F92EE;'>#EDTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6537, encryptionId=aaaf653e44, topicName=EDTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=328c12785299, createdName=ycmayy, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2049442, encodeId=3ffe204944283, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sat May 03 13:29:00 CST 2014, time=2014-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643328, encodeId=9d2116433289b, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Jun 16 03:29:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267196, encodeId=fc1c126e19600, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537050, encodeId=bedc153e0502e, content=<a href='/topic/show?id=aaaf653e44' target=_blank style='color:#2F92EE;'>#EDTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6537, encryptionId=aaaf653e44, topicName=EDTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=328c12785299, createdName=ycmayy, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=)]
    2013-11-29 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=2049442, encodeId=3ffe204944283, content=<a href='/topic/show?id=5c2e5106290' target=_blank style='color:#2F92EE;'>#心梗患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51062, encryptionId=5c2e5106290, topicName=心梗患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6a1280, createdName=zhanglin3079, createdTime=Sat May 03 13:29:00 CST 2014, time=2014-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643328, encodeId=9d2116433289b, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Jun 16 03:29:00 CST 2014, time=2014-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267196, encodeId=fc1c126e19600, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537050, encodeId=bedc153e0502e, content=<a href='/topic/show?id=aaaf653e44' target=_blank style='color:#2F92EE;'>#EDTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6537, encryptionId=aaaf653e44, topicName=EDTA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=328c12785299, createdName=ycmayy, createdTime=Fri Nov 29 01:29:00 CST 2013, time=2013-11-29, status=1, ipAttribution=)]
    2013-11-29 ycmayy